Jeremy M. Veenstra-VanderWeele, MD


New York Presbyterian Hospital, Columbia University and New York State Psychiatric Institute and Columbia University


  • Consultant: Hoffmann-La Roche Inc.; Novartis Pharmaceutical Corporation; SynapDx
  • Grant Support: American Academy of Child & Adolescent Psychiatry; Autism Speaks; Health Resources and Services Administration; National Institute of Child Health and Human Development; National Institute of Mental Health
  • Honorarium for participation in this meeting: American Academy of Child & Adolescent Psychiatry
  • Research Support: Agency for Health Care Research and Quality; Forest Laboratories, Inc.; Hoffmann-La Roche Inc.; Novartis Pharmaceutical Corporation; Seaside Therapeutics; Sunovion Pharmaceuticals Inc.

Copyright © 2015 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.